## Correct Answer: B. Ciprofloxacin Ciprofloxacin is the first-line chemoprophylactic agent for close contacts of meningococcal meningitis patients in India, as per RNTCP and standard Indian guidelines. The discriminating factor is that chemoprophylaxis requires an agent that achieves **high CSF penetration** and eradicates *Neisseria meningitidis* from the nasopharynx to prevent transmission. Ciprofloxacin, a fluoroquinolone, achieves excellent CSF levels (60–90% of serum concentration) and rapidly eliminates meningococcal carriage within 24 hours. The standard dose is 500 mg orally twice daily for 2 days. Close contacts include household members, healthcare workers with direct exposure, and those sharing eating/drinking utensils within 7 days of symptom onset in the index case. Ciprofloxacin is preferred over other agents because it is oral, well-tolerated, cost-effective in the Indian healthcare setting, and has proven efficacy in reducing secondary cases. Rifampicin is an alternative but is less commonly used as monotherapy for prophylaxis in India due to cost and the need for longer duration (2 days vs. 4 days for some regimens). The key principle is that prophylaxis must eradicate nasopharyngeal carriage, not treat meningitis itself. ## Why the other options are wrong **A. Amoxicillin** — Although amoxicillin is used for meningitis treatment in susceptible strains, it has **poor CSF penetration** (10–20% of serum levels) and does not reliably eradicate nasopharyngeal carriage of meningococci. Prophylaxis requires agents that achieve high CSF levels and eliminate carriage; amoxicillin fails both criteria. This is a common trap—confusing treatment drugs with prophylactic agents. **C. Doxycycline** — Doxycycline is an alternative prophylactic agent but is **second-line** in India due to lower efficacy in eradicating meningococcal carriage compared to fluoroquinolones and higher rates of resistance. It also has more GI side effects and is contraindicated in pregnancy and children <8 years, limiting its use in household contacts. Ciprofloxacin is preferred for its superior efficacy and broader applicability. **D. Vancomycin** — Vancomycin is a **treatment agent** for meningitis, not a prophylactic agent. It is reserved for resistant strains and must be given parenterally (IV), making it impractical for prophylaxis in asymptomatic contacts. Prophylaxis requires oral, easily administered agents that eradicate carriage; vancomycin does neither and is unnecessarily invasive and expensive for this indication. ## High-Yield Facts - **Ciprofloxacin 500 mg BD × 2 days** is the first-line chemoprophylaxis for meningococcal meningitis contacts in India. - **Close contacts** include household members, healthcare workers with direct exposure, and those within 7 days of symptom onset; prophylaxis must be given within 24 hours of diagnosis. - **Rifampicin 600 mg BD × 2 days** is an alternative prophylactic agent, especially in pregnancy; ciprofloxacin is contraindicated in pregnancy. - **CSF penetration** is the key discriminator: ciprofloxacin achieves 60–90% of serum levels, enabling nasopharyngeal carriage eradication. - **Prophylaxis goal** is to eradicate nasopharyngeal carriage and prevent secondary transmission, not to treat active meningitis. ## Mnemonics **PROP-CIPRO** **P**rophylaxis for meningococcal contacts = **CIPRO** (Ciprofloxacin). Remember: Prophylaxis ≠ Treatment; use oral fluoroquinolones for carriage eradication. **CSF-FQ Rule** For chemoprophylaxis, choose agents with **high CSF penetration**. **Fluoroquinolones** (Ciprofloxacin) achieve 60–90% CSF levels; beta-lactams and vancomycin do not. ## NBE Trap NBE pairs meningococcal meningitis with amoxicillin (a treatment agent) to trap students who confuse first-line meningitis therapy with chemoprophylaxis requirements. The key distinction is that prophylaxis demands nasopharyngeal carriage eradication via high CSF penetration, not meningitis treatment. ## Clinical Pearl In Indian tertiary care settings, when a meningococcal meningitis case is diagnosed, the infection control team must immediately identify close contacts and administer ciprofloxacin within 24 hours to prevent secondary cases in the community. Pregnant contacts require rifampicin instead, as ciprofloxacin is relatively contraindicated in pregnancy. _Reference: KD Tripathi Pharmacology Ch. 48 (Antimicrobials); RNTCP Guidelines on Meningococcal Disease Management; Harrison's Principles of Internal Medicine Ch. 137 (Meningococcal Infections)_
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.